PIK3CA and acute lymphoblastic leukemia: Genetic [17] and biochemical [6, 18, 20, 21] studies motivated us to systematically analyze the PI3K/Akt pathway using multiplex, multiparameter flow cytometry and pan- and isoform specific-PI3K inhibitor treatment in T-ALL.